Vermillion

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Vermillion and buy or sell other stocks, ETFs, and their options commission-free!

About VRML

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. 

CEO
Michael Buhle
CEOMichael Buhle
Employees
66
Employees66
Headquarters
Austin, Texas
HeadquartersAustin, Texas
Founded
1993
Founded1993
Employees
66
Employees66

VRML Key Statistics

Market cap
130.53M
Market cap130.53M
Price-Earnings ratio
-0.85
Price-Earnings ratio-0.85
Dividend yield
Dividend yield
Average volume
7.71K
Average volume7.71K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.71
52 Week high$0.71
52 Week low
$0.0201
52 Week low$0.0201

Stock Snapshot

As of today, Vermillion(VRML) shares are valued at $3.06. The company's market cap stands at 130.53M, with a P/E ratio of -0.85.

During the trading day, Vermillion(VRML) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Vermillion(VRML) stock has reached 0, versus its average volume of 7.71K.

The stock's 52-week range extends from a low of $0.02 to a high of $0.71.

The stock's 52-week range extends from a low of $0.02 to a high of $0.71.

People also own

Based on the portfolios of people who own VRML. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.